Biologic therapy of cancer.
作者信息
Dunton A W, Hanagan J, Levitt D, Spiegel R J, Zeffren J
机构信息
CIBA-GEIGY Corporation, Summit, NJ 07901.
出版信息
N J Med. 1990 Nov;87(11 Spec No):895-8.
PMID:2274296
Abstract
摘要
相似文献
1
Biologic therapy of cancer.癌症的生物治疗
N J Med. 1990 Nov;87(11 Spec No):895-8.
2
Cancer nursing: biological therapy.癌症护理：生物疗法
Nursing (Lond). 1990;4(17):20-2.
3
Biotechnology products in cancer therapy: a colloquium.癌症治疗中的生物技术产品：一场学术讨论会
Cancer Res. 1988 Jan 1;48(1):223-5.
4
Cancer chemotherapeutic and biologic agents.癌症化疗药物和生物制剂。
CA Cancer J Clin. 1993 Mar-Apr;43(2):127; author reply 127-8.
5
[Present status of studies on the application of immunology to the diagnosis and therapy of cancer, with emphasis on monoclonal antibodies and cytokines].[免疫学在癌症诊断与治疗中的应用研究现状，重点关注单克隆抗体和细胞因子]
Gan To Kagaku Ryoho. 1987 May;14(5 Pt 2):1358-66.
6
[Trends and perspectives in current cancer therapy].[当前癌症治疗的趋势与展望]
Ther Umsch. 1988 Jun;45(6):412-9.
7
Biological Response Modifiers Programme and cancer chemotherapy.生物反应调节剂计划与癌症化疗。
Int J Tissue React. 1982;4(3):173-88.
8
[So-called unconventional cancer therapy].[所谓的非传统癌症疗法]
Med Klin (Munich). 1986 May 27;81(12):423-8.
9
The biotherapy of cancer. Proceedings of a symposium May 8, 1987 Denver, Colorado.癌症生物疗法。1987年5月8日科罗拉多州丹佛市研讨会会议记录。
Oncol Nurs Forum. 1987 Nov-Dec;14(6 Suppl):1-40.
10
Applicability of phase I trial results in the design of phase II and III biological response modifier trials.I期试验结果在II期和III期生物反应调节剂试验设计中的适用性。
Cancer Treat Rep. 1985 Oct;69(10):1171-3.
Zotero 插件